Topic: neuromuscular disorders

Connect neuromuscular diagnosis with therapeutic decision-making through clinical lectures, interactive case workshops and participant case reports. The live programme addresses muscle imaging, channelopathies, myasthenic syndromes, muscular dystrophies and metabolic disorders, alongside clinical-trial methods and treatment challenges in settings with limited resources. Each day includes a 90-minute case-based workshop and discussion with experts, complemented by a library of recorded teaching. 14–16 December, 15:00–19:00 each day; Europe/Paris (CET, UTC+01:00). Entirely online, with up to 20

Support development and validation of biomarkers for neurological and neuromuscular disorders using human samples or data. Projects progress from candidate biomarker development or confirmation to validation for an intended clinical use, with milestones governing the transition between R61 and R33 phases. The combined project may last up to five years; budgets must reflect the work and are not capped by the NOFO. The next new-application deadline is 20 October 2026, at 5 p.m. in the applicant organisation’s local time.